Literature DB >> 33566168

Awakening of SCHLAFEN 11 by immunohistochemistry: a new biomarker predicting response to chemotherapy.

Reinhard Buettner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33566168      PMCID： PMC7973391          DOI： 10.1007/s00428-021-03051-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  7 in total

1.  Awakening of "Schlafen11" to Tackle Chemotherapy Resistance in SCLC.

Authors:  Katrien Berns; Anton Berns
Journal:  Cancer Cell       Date:  2017-02-13       Impact factor: 31.743

2.  SLFN11 Blocks Stressed Replication Forks Independently of ATR.

Authors:  Junko Murai; Sai-Wen Tang; Elisabetta Leo; Simone A Baechler; Christophe E Redon; Hongliang Zhang; Muthana Al Abo; Vinodh N Rajapakse; Eijiro Nakamura; Lisa M Miller Jenkins; Mirit I Aladjem; Yves Pommier
Journal:  Mol Cell       Date:  2018-02-01       Impact factor: 17.970

3.  Molecular cloning of a human DNA repair gene.

Authors:  A Westerveld; J H Hoeijmakers; M van Duin; J de Wit; H Odijk; A Pastink; R D Wood; D Bootsma
Journal:  Nature       Date:  1984 Aug 2-8       Impact factor: 49.962

4.  Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.

Authors:  Gabriele Zoppoli; Marie Regairaz; Elisabetta Leo; William C Reinhold; Sudhir Varma; Alberto Ballestrero; James H Doroshow; Yves Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

5.  Ercc1 Deficiency Promotes Tumorigenesis and Increases Cisplatin Sensitivity in a Tp53 Context-Specific Manner.

Authors:  Mladen Jokić; Ignacija Vlašić; Miriam Rinneburger; Niklas Klümper; Judith Spiro; Wenzel Vogel; Anne Offermann; Christiane Kümpers; Christian Fritz; Anna Schmitt; Arina Riabinska; Maike Wittersheim; Sebastian Michels; Luka Ozretić; Alexandra Florin; Daniela Welcker; Mehmet Deniz Akyuz; Michael Nowak; Martin Erkel; Jürgen Wolf; Reinhard Büttner; Björn Schumacher; Jürgen Thomale; Thorsten Persigehl; David Maintz; Sven Perner; Hans Christian Reinhardt
Journal:  Mol Cancer Res       Date:  2016-08-11       Impact factor: 5.852

6.  Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq.

Authors:  Tsuyoshi Takashima; Naoya Sakamoto; Junko Murai; Daiki Taniyama; Ririno Honma; Shoichi Ukai; Ryota Maruyama; Kazuya Kuraoka; Vinodh N Rajapakse; Yves Pommier; Wataru Yasui
Journal:  Virchows Arch       Date:  2020-05-30       Impact factor: 4.535

7.  Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors.

Authors:  Sandra Ortiz-Cuaran; Matthias Scheffler; Dennis Plenker; Llona Dahmen; Andreas H Scheel; Lynnette Fernandez-Cuesta; Lydia Meder; Christine M Lovly; Thorsten Persigehl; Sabine Merkelbach-Bruse; Marc Bos; Sebastian Michels; Rieke Fischer; Kerstin Albus; Katharina König; Hans-Ulrich Schildhaus; Jana Fassunke; Michaela A Ihle; Helen Pasternack; Carina Heydt; Christian Becker; Janine Altmüller; Hongbin Ji; Christian Müller; Alexandra Florin; Johannes M Heuckmann; Peter Nuernberg; Sascha Ansén; Lukas C Heukamp; Johannes Berg; William Pao; Martin Peifer; Reinhard Buettner; Jürgen Wolf; Roman K Thomas; Martin L Sos
Journal:  Clin Cancer Res       Date:  2016-06-01       Impact factor: 12.531
  7 in total
  2 in total

1.  SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243.

Authors:  Yasuhisa Murai; Ukhyun Jo; Naoko Takebe; Yves Pommier; Junko Murai; Lisa M Jenkins; Shar-Yin N Huang; Sirisha Chakka; Lu Chen; Ken Cheng; Shinsaku Fukuda
Journal:  Cancer Res       Date:  2021-04-16       Impact factor: 13.312

Review 2.  A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers.

Authors:  Bingnan Zhang; Kavya Ramkumar; Robert John Cardnell; Carl Michael Gay; C Allison Stewart; Wei-Lien Wang; Junya Fujimoto; Ignacio I Wistuba; Lauren Averett Byers
Journal:  Br J Cancer       Date:  2021-07-22       Impact factor: 9.075
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.